Antiviral and Anti-Inflammatory Plant-Derived Bioactive Compounds and Their Potential Use in the Treatment of COVID-19-Related Pathologies
The highly contagious coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been declared a global pandemic and public health emergency as it has taken the lives of over 5.7 million in more than 180 different countries. This disease is characteri...
Main Authors: | Purvi Trivedi, Amna Abbas, Christian Lehmann, H. P. Vasantha Rupasinghe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Journal of Xenobiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2039-4713/12/4/20 |
Similar Items
-
Terpenes and cannabidiol against human corona and influenza viruses–Anti-inflammatory and antiviral in vitro evaluation
by: Lior Chatow, et al.
Published: (2024-03-01) -
Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies
by: Atri Das, et al.
Published: (2023-10-01) -
Possibilities of using multidirectional immunomodulators for acute and recurrent infectious and inflammatory diseases of the upper respiratory tract
by: S. V. Morozova, et al.
Published: (2021-04-01) -
Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury
by: Xianyang Chen, et al.
Published: (2020-08-01) -
Immunopathogenesis of severe acute respiratory syndrome coronavirus-2: evolving knowledge and its current status
by: Nitin Saksena, et al.
Published: (2021-06-01)